KING & SPALDING LLP

Lobbying for INVIVYD, INC. · Biopharmacetuical

Filing Registration

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Jan 23, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Connecticut

Lobbying activity 2

Health Issues

Biopharmaceuticals, Monoclonal Antibodies, Infectious diseases, Onshoring.

Manufacturing

Biopharmaceuticals, Monoclonal Antibodies, Infectious diseases, Onshoring.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.